Can a single drug stop dengue in its tracks?
NCT ID NCT06528457
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a drug called fenretinide (ISLA101) can prevent or reduce dengue symptoms. Fifteen healthy adults were given either the drug or a placebo before or after being exposed to a weakened dengue virus. Researchers measured virus levels and immune responses over 29 days to see if the drug helps control the infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
SUNY Upstate Medical University
East Syracuse, New York, 13057, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists deliberately infect volunteers with dengue to unlock immune secrets
- Could papaya leaves help fight dengue? new trial tests the idea
- Dengue danger linked to leaky gut? new study investigates
- Exercise program aims to restore strength after dengue and chikungunya
- New dengue drug trial aims to shorten illness and lower virus levels
- Can existing COVID drug beat dengue? new trial begins